Jove
Visualize
Contact Us

Related Concept Videos

Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cost effectiveness of modalities of Palliative Biliary Drainage in Malignant Extrahepatic Biliary Obstruction.

Clinical and translational gastroenterology·2026
Same author

Risk-stratified surveillance for individuals in the UK at high risk of developing pancreatic cancer: Outcomes from the European Registry of Hereditary Pancreatic Diseases (EUROPAC).

European journal of cancer (Oxford, England : 1990)·2026
Same author

Letter to the Editor.

The American journal of gastroenterology·2026
Same author

Cost-effectiveness of biodegradable pancreatic stents in post-ERCP pancreatitis prophylaxis.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]·2025
Same author

Necrosectomy in walled-off necrosis.

Gastrointestinal endoscopy·2025
Same author

Symptom Differences in Intestinal Methanogen Overgrowth vs Small Intestinal Bacterial Overgrowth: Is Exocrine Pancreatic Insufficiency the Missing Link?

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 3, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Postinfective bile acid malabsorption: is this a long-term condition?

Shyam Menon1, Barry J M Jones

  • 1Department of Gastroenterology, Sandwell General Hospital, West Bromwich, UK. dr.s.menon@gmail.com

European Journal of Gastroenterology & Hepatology
|March 11, 2011
PubMed
Summary

Postinfective bile acid malabsorption, triggered by gastroenteritis, causes chronic diarrhea. Treatment with cholestyramine effectively manages symptoms long-term, indicating an excellent patient outlook.

More Related Videos

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
06:55

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Published on: August 21, 2017

Related Experiment Videos

Last Updated: Jun 3, 2026

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
08:42

Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport

Published on: November 27, 2016

Ileectomy-induced Bile Overaccumulation in Mouse Intestine
06:55

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Published on: August 21, 2017

Area of Science:

  • Gastroenterology
  • Clinical Medicine
  • Digestive Diseases

Background:

  • Postinfective bile acid malabsorption (PBAM) is a condition characterized by chronic diarrhea following acute gastroenteritis.
  • Patients with PBAM experience persistent digestive issues after an initial infection.

Purpose of the Study:

  • To assess the long-term clinical course and treatment outcomes for patients diagnosed with postinfective bile acid malabsorption.
  • To evaluate the efficacy and duration of cholestyramine treatment in managing chronic diarrhea in PBAM patients.

Main Methods:

  • Retrospective identification of 135 patients with a history of acute gastroenteritis.
  • Assessment of 75 patients using selenium-homocholic acid taurine tests, with results less than 10% indicating bile acid malabsorption.
  • Analysis of treatment response and long-term follow-up data for patients receiving cholestyramine.

Main Results:

  • Twenty-five patients were diagnosed with postinfective bile acid malabsorption.
  • Cholestyramine treatment significantly reduced diarrhea frequency (from 7.8 to 1.9 episodes/day, P=0.001) and dosage (from 8.2 to 5.4 g/day, P=0.005).
  • 72% of patients experienced successful diarrhea resolution with cholestyramine, with 15 out of 18 continuing treatment for a median of 6 years (range: 1-15 years).

Conclusions:

  • Postinfective bile acid malabsorption is a chronic condition requiring long-term management.
  • The long-term prognosis for patients with postinfective bile acid malabsorption is excellent, with effective symptom control using cholestyramine.